We recruit study participants from Canadian residents in the Windsor, Essex and Kent county regions.
If you wish to volunteer as a subject in one of our current or upcoming studies, please fill out the form located on this page. One of our research staff will contact you if you meet study requirements.
Aesthetic Clinical Trials
If you’re interested in participating in trials for new treatments with fillers, neurotoxins or lasers – we conduct clinical trials in aesthetic treatments in partnership with Healthy Image Center.
We are currently recruiting people with moderate to severe acne for a new laser treatment.
Clinical Trials for Skin Disease
We are recruiting for general trials based on all conditions.
Participating in a clinical trial can be a valuable opportunity to contribute to the advancement of medical research and potentially improve your own health condition.
Patient Enrollment Form
About Decision Aids
Patient decision aids (PDAs) are tools that help engage patients in making decisions about their health care. These interventions inform patients about the evidence of treatment options, assist in clarifying the relative value they place on outcomes, and guide them in the process of decision making.
They are of particular value when there are multiple treatment options with different outcomes or varying scientific uncertainty. Their use can improve knowledge, realign expectations, decrease decisional conflict, and increase patient participation in decision making. A previous PDA for psoriasis patients, for example, was shown to reduce decisional conflict and increase preparation for decision making.
About WCRI PDAs
PDAs developed by WCRI are in accordance with the International Patient Decision Aids Standards (IPDAS) and utilized evidence-based clinical practice guidelines. The PDAs can be used anytime patients desire treatment (if not treated) or are reconsidering treatment (if being treated). As a stand-alone resource, the PDAs can inform psoriasis and acne patients about their conditions, determine the severity of their condition, and contextualize treatment options. Optimally, however, we envision that it be used by patients with guidance from their physicians. Physicians may pare treatment options initially (and thereby shorten the PDA) based on medical contraindications specific to the patient, treatment availability, and treatment accessibility.